Prothena Corp Public (PRTA) Net Margin (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Net Margin of 64.05% for Q1 2026, up 219259.0% year-over-year from N/an in Q1 2025, and up 100.06% quarter-over-quarter from 102580.95% in Q4 2025.
Prothena Corp Public (PRTA) Net Margin (2012 - 2026) Analysis & Trends
Prothena Corp Public's Net Margin history runs 15 years deep, the most recent figure standing at 64.05% for Q1 2026.
- In Q1 2026, Net Margin rose 219259.0% year-over-year to 64.05%; the TTM figure through Mar 2026 stood at 260.79% (down 18077.0% YoY), while the FY2025 annual figure was 2520.57%, down 243008.0% from the prior year.
- Net Margin for Q1 2026 stood at 64.05%, up from 102580.95% in the prior quarter.
- The five-year high for Net Margin was 64.05% in Q1 2026, with the low at 144478.0% in Q1 2024.
- The 5-year median for Net Margin is 2731.09% (2024), against an average of 17434.62%.
- The sharpest annual moves came in 2024 and 2025: Net Margin slumped 14231682 bps in 2024, then jumped 14234946 bps in 2025.
- Prothena Corp Public's Net Margin stood at 12.72% in 2022, then slumped by 168003 bps to 21353.16% in 2023, then jumped by 87 bps to 2731.09% in 2024, then plunged by 3656 bps to 102580.95% in 2025, then surged by 100 bps to 64.05% in 2026.
- Business Quant data shows PRTA's Net Margin at 64.05% in Q1 2026, 102580.95% in Q4 2025, and 1511.88% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -1,839.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,839.90% |
| Mar 31, 2026 | 64.05% |
| Dec 31, 2025 | -102,580.95% |
| Sep 30, 2025 | -1,511.88% |
| Jun 30, 2025 | -2,845.41% |
| Mar 31, 2025 | -2,128.54% |
| Dec 31, 2024 | -2,731.09% |
| Sep 30, 2024 | -6,086.19% |
| Jun 30, 2024 | 50.64% |
| Mar 31, 2024 | -144,478.00% |
| Dec 31, 2023 | -21,353.16% |
| Sep 30, 2023 | 25.82% |
| Jun 30, 2023 | -1,358.57% |
| Mar 31, 2023 | -2,161.18% |
| Dec 31, 2022 | 12.72% |
| Sep 30, 2022 | -3,013.65% |
| Jun 30, 2022 | -3,145.73% |
| Mar 31, 2022 | -3,147.44% |
| Dec 31, 2021 | -2,827.82% |
| Sep 30, 2021 | 78.50% |